PATENT CLAIM ANALYSIS

Application Number: 16123430
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "024000"]

Abstract:
The present disclosure is in relation to the field of nanotechnology and cancer therapeutics. In particular, the present disclosure relates to platinum based compounds comprising platinum moiety, linker moiety and lipid moiety and corresponding nanoparticles thereof. The disclosure further relates to synthesis of said platinum based compounds, nanoparticles and compositions comprising said platinum based compounds/nanoparticles. The disclosure also relates to methods of managing cancer by employing aforesaid carbene compounds, platinum based compounds, nanoparticles and compositions thereof.

Claim (Index 12):
A compound of Formula (V): wherein:\n X 1 , X 2 , X 3  and X 4  are, independently, 0, P, S, Se, N, C, O-A, O-B, DACH, halide, chelated dicarboxylato linkage group, non-chelated dicarboxylato linkage group, or a combination thereof; \n A and B are, independently, C, P, S, N, or a combination thereof; and \n X 4  is optional.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 97.0
- Lexical Diversity: 2.07317
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14898355', '14897565', '13147751', '15182967', '11595653']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8062328036534474
- 35 USC 102 Novelty (BERT): 0.5814517947230481
- Combined Prediction Score: 0.7837547027604075
- Mean Citation Score: 348.906232
- Max Citation Score: 578.1692
- Similarity Product: 369.9752089117527

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test